Skip to main content

Table 1 Detailed drug concentrations and the calculated IC50 values of each treatment (drug concentration unit: µmol/L)

From: An integrated microfluidics platform with high-throughput single-cell cloning array and concentration gradient generator for efficient cancer drug effect screening

Treatments

Channel number

Calculated IC50

1

2

3

4

5

6

K562 cell line

SC

Ima

0

0.63

1.26

1.89

2.52

3.00

1.57

Res

0

63.21

126.18

189.15

252.12

300.00

97.15

Ima/Res

0

0.42/31.61

0.84/63.09

1.26/94.58

1.68/126.06

2/150

0.60/45.00

SCDC

Ima

0

2.95

5.89

8.83

11.77

14.00

2.99

Res

0

105.35

210.30

315.25

420.20

500.00

90.03

Ima/Res

0

1.69/52.68

3.36/105.15

5.04/157.63

6.72/210.10

8/250

1.58/49.38

AML primary cell

P1

Ara-C/DNR

0

2.11/0.42

4.21/0.84

6.31/1.26

8.40/1.68

10.0/2.0

1.75/0.35

P2

Ara-C/DNR

0

2.11/0.42

4.21/0.84

6.31/1.26

8.40/1.68

10.0/2.0

4.25/0.85

  1. SC single cell, SCDC single-cell derived clones, Ima Imatinib, Res Resveratrol, Ima/Res Imatinib combined with Resveratrol, AML acute myeloid leukemia, P1 number one patient, P2 number two patient, Ara-C Cytarabine, DNR Daunorubicin, IC50 half maximal inhibitory concentration